NZ 598600 Disclosed is the use of C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP) for the manufacture of a therapeutic preparation comprising C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP) as the active ingredient for the treatment of rhinitis.